Nykode Therapeutics - Mandatory Notification of Trade
Nykode Therapeutics ASA (NYKD) · publisert 20. desember 2024 kl. 14:19 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass |
|---|---|---|---|---|---|---|---|
| Christian Åbyholm via Caaby AS | Styremedlem | Kjøp Overføring | 100 000 | 3 NOK | 20. desember 2024 | NO0010714785 | XOSL - Oslo Stock Exchange |
| Christian Åbyholm | Styremedlem | Salg Overføring | 100 000 | 3 NOK | 20. desember 2024 | NO0010714785 | XOSL - Oslo Stock Exchange |
Vedlegg
- 241220 Attachment.pdf (application/pdf, originaldokument)
Meldingstekst
Oslo, Norway, December 20, 2024
Caaby AS has today acquired 100,000 shares in Nykode Therapeutics ASA at an average price of NOK 3.0 per share. Christian Åbyholm is the 100% owner of Caaby AS and is a Member of the Board of Directors and primary insider in Nykode Therapeutics ASA. Following the transaction Caaby AS holds 2,155,295 shares in Nykode Therapeutics ASA.
Christian Åbyholm has today sold 100,000 shares in Nykode Therapeutics ASA at an average price of NOK 3.0 per share. Christian Åbyholm is a Member of the Board of Directors and primary insider in Nykode Therapeutics ASA. Following the transaction Christian Åbyholm holds 0 shares in Nykode Therapeutics ASA.
For further details, please see the attached form.